Doris Molina-Henry, Ph.D., obtained a B.S. in Biology from Elon University in North Carolina, followed by her Ph.D. in Neurobiology and Anatomy from Wake Forest School of Medicine. She began her work in Alzheimer’s disease and clinical trials as an affiliate faculty member to the Wake Forest Alzheimer’s Disease Research Center. She later completed advance training in clinical trials as a fellow for the Institute on Methods and Protocols for the Advancement of Clinical Trials in ADRD in 2020. Dr. Molina-Henry is currently an Assistant Professor of Neurology at the University of Southern California’s Keck School of Medicine. She is a faculty member within the Alzheimer’s Therapeutic Research Institute and part of the Recruitment and Retention Unit Leadership for the Alzheimer’s Clinical Trials Consortium. Her research focuses on the exploration and evaluation of recruitment and retention strategies and outreach programs to support engagement and participation of underrepresented groups in Alzheimer’s disease clinical trials. She is also interested in the role of blood-based biomarkers in establishing participant eligibility to AD clinical trials.